BIOMAT Database Logo BIOMAT Database Logo

[On the suppression of protein synthesis and stimulation of RNA synthesis during the action of some antibiotics on Bacillus subtilis mutants]. 1969

M V Bibikova, and G F Gauze, and G V Kochetkova

UI MeSH Term Description Entries
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005827 Genetics, Microbial A subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms. Microbial Genetics,Genetic, Microbial,Microbial Genetic
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto

Related Publications

M V Bibikova, and G F Gauze, and G V Kochetkova
[Guanosine polyphosphate concentration and stable RNA synthesis in Bacillus subtilis following suppression of protein synthesis].
January 1980, Molekuliarnaia biologiia,
M V Bibikova, and G F Gauze, and G V Kochetkova
Action Of Three Antibiotics On Some strains Of Bacillus Subtilis and Neighboring Germs.
February 1948, Comptes rendus des seances de la Societe de biologie et de ses filiales,
M V Bibikova, and G F Gauze, and G V Kochetkova
[Ability of lectins to model the action of antibiotics on growth of mutants of Bacillus subtilis].
January 2005, Ukrains'kyi biokhimichnyi zhurnal (1999 ),
M V Bibikova, and G F Gauze, and G V Kochetkova
[Investigation of Bacillus subtilis exolectin ability to modulate the antibiotics effect on growth of Bacillus subtilis mutants].
January 2006, Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993),
M V Bibikova, and G F Gauze, and G V Kochetkova
RNA synthesis during spore germination in Bacillus subtilis.
September 1979, Molecular & general genetics : MGG,
M V Bibikova, and G F Gauze, and G V Kochetkova
Morphology and patterns of protein synthesis during sporulation of Bacillus subtilis Eryr spo(Ts) mutants.
May 1979, Journal of bacteriology,
M V Bibikova, and G F Gauze, and G V Kochetkova
Synthesis of ribosomal RNA during sporulation in Bacillus subtilis.
April 1975, Nature,
M V Bibikova, and G F Gauze, and G V Kochetkova
Pleiotropic, extragenic suppression of dna mutants in Bacillus subtilis.
October 1976, Journal of bacteriology,
M V Bibikova, and G F Gauze, and G V Kochetkova
Quantitative regulation of RNA synthesis during sporulation of Bacillus subtilis.
March 1964, Biochemical and biophysical research communications,
M V Bibikova, and G F Gauze, and G V Kochetkova
Minicell yield and cell division suppression in Bacillus subtilis mutants.
March 1975, Journal of bacteriology,
Copied contents to your clipboard!